4 January 2022
IQ-AI Ltd
("IQ-AI" or the "Company")
Director/PDMR Shareholding
IQ-AI announces that Michael Schmainda, Director of IQAI and CEO of Imaging Biometrics, has been granted an option to subscribe for 5,969,792 ordinary shares of 1p each in the Company ("Ordinary Shares") at an exercise price of 5.88p per share. The option will vest on 15 December 2024.
Michael Schmainda is currently interested in 9,108,400 Ordinary Shares, representing 4.99 per cent. of the voting rights of the Company.
The Directors of the Company accept responsibility for the contents of this announcement
-ENDS-
For further information, please contact:
| IQ-AI Limited Trevor Brown/Brett Skelly/Vinod Kaushal Tel: 020 7469 0930 |
|
Peterhouse Capital Limited (Financial Adviser and Broker) Lucy Williams/Heena Karani Tel: 020 7220 9797 |
| Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. | ||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Michael Schmainda |
| 2 | Reason for the notification | |
| a) | Position/status | Director of the Company |
| b) | Initial notification /Amendment |
Initial |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | IQ-AI Limited |
| b) | LEI | 213800SPW48XRJS2QH57 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 1p each
ISIN: JE00BD4H0R42 |
| b) | Nature of the transaction | Grant of Option
|
| c) | Price(s) and volume(s) | 5,969,792 ordinary shares at 5.88p per share
|
| d) | Aggregated information - Aggregated volume - Price |
N/A (single transaction)
|
| e) | Date of the transaction | 15 December 2021
|
| f) | Place of the transaction | N/A |
Market Abuse Regulation (MAR) Disclosure
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 as it forms part of retained EU law (as defined in the European Union (Withdrawal) Act 2018).
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
